B+
Overall grade
B+
Financial quality
The sleeper story is Conifer's AI-driven revenue cycle becoming a genuine competitive moat as DSOs hit record lows while the industry struggles with increased denials. The obvious headline is the massive guidance raise, but the real story is they're hitting capacity constraints and choosing margin expansion over volume growth. The binding constraint is clearly hospital capacity - they cut volume guidance while raising EBITDA by $325M. As Sutaria said, 'we can return to following our overall SWB inflation rather than just being focused on contract labor expenses.' My view changes if contract labor metrics reappear next quarter showing deterioration, or if they start sacrificing margins to chase volume growth.
The 30-second version
- The sleeper story: Conifer's AI-driven revenue cycle is quietly becoming a competitive moat
- Massive guidance raise ($395M EBITDA increase) driven by fundamental strength, not one-timers
- Volume guidance cut despite strong quarter signals capacity constraints emerging
What changed this quarter
| Metric | Prior | This quarter |
|---|---|---|
| Net Operating Revenues | $5.2B (Q1) | $5.3B (Q2) |
| Consolidated Adjusted EBITDA | $1.163B (Q1) | $1.121B (Q2) |
| EBITDA Margin | 22.3% (Q1) | 21.3% (Q2) |
| USPI Same Facility Revenue Growth | 6.8% (Q1) | 7.7% (Q2) |
| USPI Revenue per Case | 9.1% (Q1) | 8.3% (Q2) |
| Hospital Same-Store Admissions | 4.4% (Q1) | 1.6% (Q2) |
| Revenue per Adjusted Admission | 2.8% (Q1) | 5.2% (Q2) |
| SWB as % of Revenues | 40.6% (Q1) | 41% (Q2) |
Accountability tracked
6 new promises made5 narrative shifts flagged6 prior promises graded
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Subscribe to Call Sheet Daily →